# Wearlinq

> Wearlinq is a San Francisco healthtech company building eWave, described as the first continuous, wireless, FDA 510(k)-cleared 6-lead ECG cardiac monitor. About the size of a coin and worn on a skin-like adhesive patch, eWave pairs with a patient's own smartphone, runs 5+ days between charges in an AirPods-style case, and streams near-real-time data so clinicians get hospital-grade multi-lead visibility without the bulk of a wired Holter monitor. The company also operates an IDTF (independent diagnostic testing facility) staffed by certified cardiographic technicians who turn around STAT reports, closing the loop from device to diagnosis.

- **Founded:** 2019
- **Headquarters:** San Francisco, California, United States
- **Founders:** Konrad Morzkowski (Co-founder & CEO), Albert Rogers (Co-founder (Stanford electrophysiologist))
- **Team size:** ~39 employees
- **Products:** eWave, LiveLinq, Patient Mobile App, Wearlinq IDTF
- **Notable:** Built the first continuous, wireless, FDA 510(k)-cleared 6-lead ECG cardiac monitor (eWave)., Raised roughly $26M across rounds, including a $14M Series A led by AIX Ventures plus $5M venture debt (Dec 2025)., Acquired AMI Cardiac Monitoring to bring diagnostic reporting in-house and expand clinical services nationwide.

## Products & services

- **eWave** — A continuous, wireless, FDA 510(k)-cleared 6-lead ECG cardiac monitor. Lightweight and discreet, it magnetically attaches to skin-like (patent-pending) adhesive patches, pairs over Bluetooth with the patient's own phone, runs 5+ days per charge, and delivers near-real-time data plus clinician reports in under 48 hours.
- **LiveLinq** — A clinical platform offering beat-by-beat ECG waveform interpretation, full visibility into patient studies across modalities, and configurable displays with zoom for detailed signal analysis.
- **Patient Mobile App** — Bluetooth companion app with a Digital Diary that matches EKG strips to patient-logged events, connectivity checks and patch alerts, immediate data transmission, and 24/7 concierge support.
- **Wearlinq IDTF** — An independent diagnostic testing facility with 33+ years of ambulatory monitoring experience (via the AMI Cardiac Monitoring acquisition), staffed round-the-clock by certified cardiographic technicians producing timely, high-quality reports including daily STAT reports.

## Achievements

- Built the first continuous, wireless, FDA 510(k)-cleared 6-lead ECG cardiac monitor (eWave).
- Raised roughly $26M across rounds, including a $14M Series A led by AIX Ventures plus $5M venture debt (Dec 2025).
- Acquired AMI Cardiac Monitoring to bring diagnostic reporting in-house and expand clinical services nationwide.
- Reported use by 1,000+ patients nationwide.
- CEO Konrad Morzkowski named to a Forbes 30 Under 30 list.

## Latest updates

- **2025-12** — Raised $14M Series A (led by AIX Ventures) plus $5M in venture debt to scale the eWave monitor.
- **2024-10** — Seed round closed (reported ~$700K).
- **2024-05** — Announced acquisition of AMI Cardiac Monitoring, LLC, expanding nationwide clinical services around its FDA 510(k)-cleared 6-lead device.

## Links

- Website: https://wearlinq.com
- LinkedIn: https://www.linkedin.com/company/wearlinq

---

Profile page: https://yespress.io/wearlinq
Published by YesPress — https://yespress.io
Last updated: 2026-07-02